Total Payments
$6,430
2024 Payments
$955.40
Companies
23
Transactions
287
Medicare Patients
1,700
Medicare Billing
$182,967
Payment Breakdown by Category
Food & Beverage$6,213 (96.6%)
Other$216.92 (3.4%)
Education$0.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,213 | 284 | 96.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $216.92 | 2 | 3.4% |
| Education | $0.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,583 | 156 | $0 (2024) |
| Amgen Inc. | $381.17 | 23 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $308.27 | 28 | $0 (2021) |
| Allergan, Inc. | $304.33 | 11 | $0 (2021) |
| SK Life Science, Inc. | $258.57 | 4 | $0 (2024) |
| Greenwich Biosciences, Inc. | $235.95 | 5 | $0 (2021) |
| Eisai Inc. | $183.43 | 5 | $0 (2021) |
| Lilly USA, LLC | $172.31 | 10 | $0 (2024) |
| EMD Serono, Inc. | $140.17 | 6 | $0 (2021) |
| GENZYME CORPORATION | $129.90 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $955.40 | 40 | ABBVIE INC. ($729.45) |
| 2023 | $1,030 | 38 | ABBVIE INC. ($763.92) |
| 2022 | $1,502 | 61 | ABBVIE INC. ($1,112) |
| 2021 | $2,573 | 128 | AbbVie Inc. ($978.02) |
| 2020 | $370.02 | 20 | Lilly USA, LLC ($66.85) |
All Payment Transactions
287 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Neuropsychiatry | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: PAIN | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: Neurology | ||||||
| 07/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 06/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 499 | 797 | $96,158 | $52,836 |
| 2022 | 12 | 484 | 728 | $105,302 | $56,787 |
| 2021 | 11 | 483 | 697 | $96,669 | $53,985 |
| 2020 | 7 | 234 | 303 | $34,464 | $19,359 |
Total Patients
1,700
Total Services
2,525
Medicare Billing
$182,967
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 200 | $29,180 | $17,664 | 60.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 144 | $15,198 | $8,581 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 110 | $10,948 | $6,581 | 60.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 68 | 157 | $10,375 | $5,727 | 55.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 61 | 62 | $8,326 | $3,866 | 46.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 38 | $5,716 | $3,424 | 59.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $6,758 | $2,906 | 43.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $4,321 | $2,162 | 50.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,424 | $994.53 | 41.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 22 | 23 | $2,912 | $929.79 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 267 | $37,856 | $22,332 | 59.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 53 | $12,231 | $6,841 | 55.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 38 | 84 | $12,236 | $6,355 | 51.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 51 | 95 | $9,703 | $5,018 | 51.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $6,696 | $3,201 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 39 | $3,792 | $2,392 | 63.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $4,021 | $2,167 | 53.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 27 | 27 | $3,450 | $2,036 | 59.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 14 | $3,241 | $1,570 | 48.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 32 | 33 | $4,012 | $1,421 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,254 | $1,416 | 43.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 45 | $2,949 | $1,210 | 41.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,861 | $829.00 | 44.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 261 | $36,540 | $22,170 | 60.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 53 | 66 | $15,048 | $8,237 | 54.7% |
About Dr. Matthew Hileman, DO
Dr. Matthew Hileman, DO is a Neurology healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1912357161.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Hileman, DO has received a total of $6,430 in payments from pharmaceutical and medical device companies, with $955.40 received in 2024. These payments were reported across 287 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,213).
As a Medicare-enrolled provider, Hileman has provided services to 1,700 Medicare beneficiaries, totaling 2,525 services with total Medicare billing of $182,967. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Springfield, IL
- Active Since 06/19/2016
- Last Updated 12/01/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1912357161
Products in Payments
- UBRELVY (Drug) $2,894
- QULIPTA (Drug) $776.05
- NURTEC ODT (Drug) $468.58
- Aimovig (Biological) $381.17
- XCOPRI (Drug) $249.20
- Epidiolex (Drug) $235.95
- EMGALITY (Drug) $151.57
- BOTOX (Biological) $151.19
- ANDEXXA (Biological) $118.66
- Dayvigo (Drug) $109.79
- APTIOM (Drug) $91.27
- Aduhelm (Drug) $73.64
- KESIMPTA (Drug) $70.20
- VRAYLAR (Drug) $66.24
- ZIPSOR (Drug) $62.18
- Mavenclad (Drug) $60.51
- NUPLAZID (Drug) $52.00
- Briviact (Drug) $50.86
- XARELTO (Drug) $30.44
- REYVOW (Drug) $20.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Springfield
David Clark, Do, DO
Neurology — Payments: $1.1M
Neurology $1.1M
Raymond Englander, Md, MD
Neurology — Payments: $167,481
Neurology $167,481
Dr. Jenifer Zhai, Md, MD
Neurology — Payments: $121,314
Neurology $121,314
Cecile Becker, M.d, M.D
Neurology — Payments: $78,042
Neurology $78,042
Jennifer Lynch, Md, MD
Neurology — Payments: $73,454
Neurology $73,454
Jayant Acharya, Md, MD
Neurology — Payments: $56,046
Neurology $56,046